Journal of the American Heart Association

Long-term effects of diabetes drugs on patients with artery disease and type 2 diabetes

Updated

Abstract

More than 236 million people globally are affected by peripheral artery disease (PAD), particularly those with type 2 diabetes.

  • GLP-1 receptor agonists may provide cardiovascular and kidney benefits.
  • The effects of GLP-1 receptor agonists on specific outcomes related to PAD are not well understood.
  • This study aims to evaluate the long-term effects of GLP-1 receptor agonists on adverse outcomes in individuals with PAD.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free